2025-09-28 - Analysis Report
Okay, here's a report summarizing the analysis of Hims & Hers Health Inc. (HIMS), incorporating the provided data and analysis requests.

## HIMS Stock Analysis (September 27, 2025)

**Ticker:** HIMS
**Company:** Hims & Hers Health Inc.
**Description:** Hims & Hers Health is a multi-specialty telehealth platform offering personalized health and wellness solutions.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 258.31%
*   **VOO Cumulative Return:** 54.93%
*   **Absolute Difference:** 203.38%
*   **Spread Analysis:**
    *   Max: 137.9
    *   Min: -64.0
    *   Current: 27.9
    *   Relative Spread: 45.5

**Analysis:** HIMS has significantly outperformed the S&P 500 over the analyzed period.  The current spread of 27.9 indicates that HIMS is performing above VOO. However, a relative spread of 45.5 suggests that its current performance, while positive, is positioned at the middle of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
|------------|---------|---------|--------|------|--------|
| 2019-2021  | -36.0%  | 70.7%   | -63.0% | 0.1  | 1.5    |
| 2020-2022  | -10.0%  | 78.7%   | -24.0% | 0.0  | 1.4    |
| 2021-2023  | -60.0%  | 78.7%   | -77.0% | -0.3 | 2.0    |
| 2022-2024  | 112.0%  | 79.3%   | 99.0%  | -0.2 | 5.5    |
| 2023-2025  | 252.0%  | 80.8%   | 217.0% | 0.4  | 13.2   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant volatility across different periods, ranging from substantial losses to impressive gains. The 2023-2025 period stands out with a remarkable 252% CAGR.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high across all periods, indicating significant risk and volatility in the stock's price.
*   **Alpha:** Alpha values are highly variable, with large negative values in earlier periods and a significant positive value of 217% in the 2023-2025 period, reflecting substantial outperformance compared to the benchmark.
*   **Beta:** Beta values range from -0.3 to 13.2, indicating fluctuating sensitivity to market movements. The recent period (2023-2025) shows an extremely high beta of 13.2, suggesting the stock is highly reactive to market changes and potentially more volatile than the market.
*   **Market Capitalization:** The company's capitalization has increased significantly over time, indicating growth and investor confidence.

### 2. Recent Price Action

*   **Current Price:** $58.40
*   **Last Market Change:** Price: 58.4, Previous Close: 54.87, Change: 6.43
*   **5-day Moving Average:** 55.62
*   **20-day Moving Average:** 51.41
*   **60-day Moving Average:** 51.16

**Analysis:** The stock is trading above its 5, 20, and 60-day moving averages, indicating a bullish trend.  The recent significant price increase (change of $6.43) suggests a strong positive catalyst. This rapid increase can be seen as a potential "jump".

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 63.72
*   **PPO:** 1.24
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (3237 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Spread Change:** 4.1 (+)
*   **Expected Return (%):** -30.3%

**Analysis:**

*   The **MRI of 0.9** suggests that the model considers HIMS a relatively safe investment at the moment.
*   **RSI of 63.72** indicates that the stock is approaching overbought territory but is not there yet.
*   **PPO of 1.24** suggests a potential upward trend in momentum, as the short-term moving average is above the long-term moving average.
*   The **Hybrid Signal** is a strong buy signal, further reinforcing the positive outlook.
*   The **recent increase in relative spread** (4.1) supports the short-term bullish sentiment.
*   The **expected return of -30.3%** suggests that, from the current price, the model anticipates HIMS to underperform the S&P 500 over a long-term investment horizon. This contrasts with the shorter-term positive signals.

### 4. Recent News & Significant Events

*   **Mixed Sentiment:** Recent news headlines present a mixed picture.  Some articles highlight HIMS as a potentially better investment than competitors (DOCS), and a trending stock with positive momentum. However, other articles point to insider selling, volatility, and underperformance compared to the broader market.
*   **Insider Selling:** The reported insider selling of shares worth $1,361,766 could be a cause for concern.
*   **Volatility:** Multiple articles refer to HIMS as a volatile stock.

### 4-2. Analyst Opinions

*   **Consensus:** Hold
*   **Mean Rating:** 2.92 (~Hold)
*   **Number of Opinions:** 12
*   **Target Price:**
    *   Average: $47.42
    *   High: $85.00
    *   Low: $25.00

**Analysis:** Analyst consensus is a "Hold," with a mean rating around the neutral mark. The wide range in target prices ($25 to $85) reflects significant disagreement among analysts regarding the stock's future value.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-08-04 | 0.19 | 0.54 B$ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2025-08-04 | 0.06 | 0.32 B$ |

**Analysis:** The earnings per share (EPS) and revenue data show fluctuations.  EPS has varied, and revenue has generally increased over the past year.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.54B  | 76.39%        |
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE    |
|------------|---------|--------|
| 2025-06-30 | $0.56B  | 7.55%  |
| 2025-03-31 | $0.55B  | 9.01%  |
| 2024-12-31 | $0.48B  | 5.46%  |
| 2024-09-30 | $0.44B  | 17.18% |
| 2024-06-30 | $0.36B  | 3.67%  |

**Analysis:** Revenue has been growing, indicating business expansion. Profit margins are consistently high, suggesting strong operational efficiency. Equity has also increased, reflecting a strengthening financial position.  The Return on Equity (ROE) has fluctuated, indicating variability in profitability relative to equity.

### 7. Overall Assessment

HIMS presents a mixed investment picture.

**Positive Signals:**

*   Significant outperformance vs. S&P 500 in the past.
*   Recent bullish price action.
*   Positive short-term technical indicators (MRI, RSI, PPO, Hybrid Signal).
*   Revenue growth and high profit margins.

**Concerns:**

*   High volatility (MDD and Beta).
*   Insider selling.
*   Analyst consensus is "Hold" with a wide range of target prices.
*   Negative long-term expected return relative to the S&P 500.
*   Recent significant price increase might be unsustainable.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted.

*   **Short-Term:** The technical indicators and recent price action suggest potential for continued short-term gains. However, the stock may be overbought soon.
*   **Long-Term:** The negative expected return and analyst uncertainty suggest caution for long-term investment. Further research into the reasons for the negative expected return is recommended.
*   **Risk Management:** Due to the high volatility, appropriate risk management strategies (e.g., stop-loss orders) are essential.

The recent sharp price increase and the insider selling need to be considered carefully. Monitor news and financial reports closely for any further developments.
